Literature DB >> 25115709

Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development.

Meng Zhu1, Ning Zhang2, Shuixiang He3.   

Abstract

Evidence increasingly suggests that miR-106a is always elevated in gastric cancer; however, little is known about the expression trend and clinical significance in the whole process of gastric carcinogenesis and development. To investigate the dynamic changes of miR-106a in each stage during gastric carcinogenesis, we used formalin-fixed, paraffin-embedded (FFPE) tissues which had been reported to have valuable information for miRNA research in our previous studies. Here, we compared the expression of miR-106a in FFPE and fresh frozen tissues using real-time polymerase chain reaction. On the basis of the high correlation of miR-106a quantitative data from the two resources, FFPE samples were subsequently performed to elucidate the location and expression of miR-106a using in situ hybridization in sequential tissues, including normal gastric mucosa, chronic atrophic gastritis combined with various degrees of dysplasia, early and advanced gastric cancer. Finally, we found that miR-106a was similarly up-regulated in gastric cancer regardless of sample types although fragmentation existed inevitably in FFPE tissues. Notably, the frequency and extent of miR-106a expression gradually increased during the transition from atypical hyperplasia to advanced carcinoma and had already had positive signals in early precancerous lesions but negative signals in normal gastric mucosal epithelial cells. Our research, according to these results, indicated that FFPE samples can serve as an important research tool for miRNA field, and the early changes of miR-106a detected in such samples may have clinical application as a potential biomarker for the discovery and diagnosis of gastric cancer.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Early diagnosis; Formalin-fixed paraffin-embedded; Gastric cancer; In situ hybridization; MicroRNA-106a

Mesh:

Substances:

Year:  2014        PMID: 25115709     DOI: 10.1016/j.prp.2014.07.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

1.  Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer.

Authors:  Gang Chen; Yong Tang; Jiang-Hua Wu; Feng-Hua Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

3.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

4.  MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.

Authors:  Meng Zhu; Ning Zhang; Shuixiang He; Ruirui Yan; Jun Zhang
Journal:  Clin Exp Metastasis       Date:  2016-05-03       Impact factor: 5.150

5.  MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.

Authors:  Bo Tang; Biao Lei; Guangying Qi; Xingsi Liang; Fang Tang; Shengguang Yuan; Zhenran Wang; Shuiping Yu; Songqing He
Journal:  J Exp Clin Cancer Res       Date:  2016-06-16

6.  Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.

Authors:  Yuzheng He; Guiqi Wang; Lei Zhang; Congjie Zhai; Jun Zhang; Xusheng Zhao; Xia Jiang; Zengren Zhao
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

7.  miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.

Authors:  Yong Chen; Lingfeng Min; Chuanli Ren; Xingxiang Xu; Jianqi Yang; Xinchen Sun; Tao Wang; Fang Wang; Changjiang Sun; Xizhi Zhang
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

8.  Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyunsung Kim; Su-Jin Shin; Dong-Hoon Kim; Seung Sam Paik; Kiseok Jang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  MicroRNA Expression Profiles in Gastric Carcinogenesis.

Authors:  Jinha Hwang; Byung-Hoon Min; Jiryeon Jang; So Young Kang; Hyunsik Bae; Se Song Jang; Jong-Il Kim; Kyoung-Mee Kim
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

10.  A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer.

Authors:  Dennis Poel; Elske C Gootjes; Lotte Bakkerus; Wim Trypsteen; Henk Dekker; Hans J van der Vliet; Nicole C T van Grieken; Cornelis Verhoef; Tineke E Buffart; Henk M W Verheul
Journal:  Cancer Med       Date:  2020-08-30       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.